The Claim
Genetically reduced PCSK9 function is associated with a 14% lower risk of all-cause dementia in a trans-ethnic cohort of 312,097 individuals, with an odds ratio of 0.86 (95% CI: 0.78–0.93, p = 5.0 × 10⁻⁴), indicating that lifelong lower LDL cholesterol due to PCSK9 genetic variation may protect against cognitive decline, potentially through vascular mechanisms.
What the research says
Supports is higher
Support is ahead, but a single strong opposing study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
People born with a certain gene change that lowers their bad cholesterol over their whole life might have a lower chance of getting dementia, and this could be because of better blood vessel health in the brain.
See the scientific wording
Genetically reduced PCSK9 function is associated with a 14% lower risk of all-cause dementia in a trans-ethnic cohort of 312,097 individuals, with an odds ratio of 0.86 (95% CI: 0.78–0.93, p = 5.0 × 10⁻⁴), suggesting that lifelong lower LDL-C due to PCSK9 variation may protect against cognitive decline, potentially through vascular mechanisms.
What the research says
1 studyThe study looked at people with natural genetic changes that lower PCSK9 and found they have a lower risk of dementia, just like the claim says.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.